Being an Everyday Hero For Patients With MPN
In the 2020 Hematology 1 special edition of CURE magazine, we highlight what it means to be an everyday hero by living with MPN or helping patients with the disease cope with it.
Remission Drives Ambition: Experts Look to New Methods in AML Treatment
Targeted therapies have changed the landscape of cancer care, and now, hope for remission is a possibility for certain patients with acute myeloid leukemia with new approved therapies.
Overcoming Multiple Myeloma Takes One Patient to New Heights
Terry White, who has lived with multiple myeloma for more than a decade, offers reassurance to other patients.
Eyes On New Treatments Beyond Chemotherapy in Diffuse Large B-cell Lymphoma
Patients with relapsed and resistant diffuse large B-cell lymphoma can look to new treatments beyond tried-and-true chemotherapy.
Speaking Out: Treatment Options May Expand in Mantle Cell Lymphoma
An expert sheds light on the latest therapies in clinical trials and promising drug combinations to thwart the aggressive disease.
Extending the Options for Patients with AML by Making It Personal
A wave of new targeted therapies expands the options in acute myeloid leukemia.
Transitioning to Targeted Treatment for Patients with CLL Using BTK Inhibitors
Newer medications that displace chemotherapy aim directly at mutations in the Bruton tyrosine kinase gene and help patients with CLL live longer.
2 Clarke Drive Cranbury, NJ 08512